Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.33 |
| ▸ | CCNE2 | O96020 | 2/20 | 0.33 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.33 |
| ▸ | CDK2 | P24941 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9977607 | 0.88 | CYP1A2 (0.36) | ALOX5CYP1A2CYP2C19SMN1; SMN2L3MBTL1 | |
| SCHEMBL15015192 | 0.86 | SMN1; SMN2 (0.36) | ALOX5CYP1A2CYP2C19SMN1; SMN2L3MBTL1 | |
| SCHEMBL92981 | 0.77 | CCNE2 (0.39) | ALOX5CYP1A2CYP2C19SMN1; SMN2L3MBTL1 | |
| SCHEMBL16946102 | 0.73 | CCNE2 (0.38) | ALOX5CYP1A2CYP2C19SMN1; SMN2L3MBTL1 | |
| SCHEMBL92990 | 0.71 | SMN1; SMN2 (0.40) | ALOX5CYP1A2CYP2C19SMN1; SMN2L3MBTL1 | |
| SCHEMBL12697311 | 0.70 | CYP1A2 (0.51) | CYP1A2CYP2C19SMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL7095147 | 0.68 | CYP1A2 (0.56) | CYP1A2CYP2C19SMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL82039 | 0.67 | PTPN1 (0.46) | CYP2C19SMN1; SMN2L3MBTL1ALDH1A1KDM4E | |
| SCHEMBL15728540 | 0.65 | L3MBTL1 (0.47) | CYP1A2CYP2C19SMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL17934385 | 0.65 | TSHR (0.44) | CYP1A2CYP2C19SMN1; SMN2L3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170334858-A1 | PROCESS FOR THE PREPARATION OF INTERMEDIATE OF DOLUTEGRAVIR | HETERO RESEARCH FOUNDATION (IN) | 2017-11-23 | — | — | US | disclosed |
| WO-2015001572-A2 | PROCESS FOR THE PREPARATION OF INTERMEDIATE OF DOLUTEGRAVIR | HETERO RESEARCH FOUNDATION (IN) | 2015-01-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170334858-A1 | PROCESS FOR THE PREPARATION OF INTERMEDIATE OF DOLUTEGRAVIR | CYP3A4, DHPS, MVD | ALOX5 1988/4885CYP1A2 42/4885CYP2C19 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.